Exploring Learnings From Translational & Clinical Development of Dolaflexin & Dolasynthen ADCs

Time: 5:00 pm
day: Day One PM


  • Contrasting and sharing pre-clinical and clinical data for Dolaflexin and Dolasynthen ADCs, employing the same payload and same antibody
  • Predicting and evaluating differences in clinical efficacy and tolerability performance based on preclinical data – what are the core lessons?
  • Breaking down how differences in ADC design impact clinical performance